|Videos|August 24, 2022

Patient Selection for Atopic Dermatitis Therapies

Author(s)Raj Chovatiya, MD, PhD, Elizabeth Swanson, MD, Korey Capozza, MPH

Elizabeth A. Swanson, MD, provide insight on identifying the appropriate patients for various therapeutic regimens in atopic dermatitis.

Episodes in this series

EP. 1 Patient Presentation of Atopic Dermatitis

EP. 1 Patient Presentation of Atopic Dermatitis

EP. 2 Patient Diagnosis and Early Treatment of Atopic Dermatitis

EP. 2 Patient Diagnosis and Early Treatment of Atopic Dermatitis

EP. 3 Impact of Atopic Dermatitis on QoL

EP. 3 Impact of Atopic Dermatitis on QoL

EP. 4 Addressing Lack of Atopic Dermatitis Education

EP. 4 Addressing Lack of Atopic Dermatitis Education

EP. 5 Clinical Presentation of Atopic Dermatitis

EP. 5 Clinical Presentation of Atopic Dermatitis

EP. 6 The Effect of Atopic Dermatitis on Pediatric and Adult Patients

EP. 6 The Effect of Atopic Dermatitis on Pediatric and Adult Patients

EP. 7 Approaching the Management of Atopic Dermatitis

EP. 7 Approaching the Management of Atopic Dermatitis

EP. 8 Patient Selection for Atopic Dermatitis Therapies

EP. 8 Patient Selection for Atopic Dermatitis Therapies

EP. 9 Using Multidisciplinary Care to Optimize Atopic Dermatitis Treatment

EP. 9 Using Multidisciplinary Care to Optimize Atopic Dermatitis Treatment

EP. 10 Pharmacologic Treatment Options for Atopic Dermatitis

EP. 10 Pharmacologic Treatment Options for Atopic Dermatitis

EP. 11 Role of Disease-Modifying Therapies for Atopic Dermatitis Treatment

EP. 11 Role of Disease-Modifying Therapies for Atopic Dermatitis Treatment

EP. 12 Barriers to Access for Atopic Dermatitis Therapies

EP. 12 Barriers to Access for Atopic Dermatitis Therapies

EP. 13 Patient Advocacy for Atopic Dermatitis

EP. 13 Patient Advocacy for Atopic Dermatitis

EP. 14 Key Takeaways for Atopic Dermatitis Management

EP. 14 Key Takeaways for Atopic Dermatitis Management

EP. 15 Unmet Needs in Managing Atopic Dermatitis

EP. 15 Unmet Needs in Managing Atopic Dermatitis

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Contemporary Pediatrics

FAQ: What's new in COVID-19, RSV, and flu guidance?

FDA approves leniolisib for children aged 4 to 11 with APDS

A teenaged girl with flat-topped papules

From index of suspicion to managing survivorship: A primary care toolkit for childhood cancer

XOCOVA offers new post-exposure COVID-19 prevention option for adolescents